Vestcor Inc’s Halozyme HALO Stock Holding History

Vestcor Inc’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Sell	24,113 -9,399	-28%	-$663K	0.04%	387
2025 Q4	$2.25M	Sell	33,512 -9,299	-22%	-$626K	0.06%	301
2025 Q3	$3.14M	Sell	42,811 -1,802	-4%	-$120K	0.09%	231
2025 Q2	$2.32M	Buy	+44,613	New	+$2.54M	0.07%	299
2025 Q1	–	Sell	-9,831	Closed	-$470K	–	1209
2024 Q4	$470K	Hold	9,831	–	–	0.02%	701
2024 Q3	$563K	Hold	9,831	–	–	0.02%	652
2024 Q2	$515K	Hold	9,831	–	–	0.02%	649
2024 Q1	$400K	Hold	9,831	–	–	0.01%	727
2023 Q4	$363K	Hold	9,831	–	–	0.01%	772
2023 Q3	$376K	Buy	+9,831	New	+$403K	0.01%	734
2023 Q2	–	Sell	-5,932	Closed	-$227K	–	1110
2023 Q1	$227K	Hold	5,932	–	–	0.01%	845
2022 Q4	$338K	Buy	+5,932	New	+$304K	0.01%	759

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vestcor Inc's HALO Position: Q1 2026 in Review

Vestcor Inc reduced its Halozyme (HALO) stake by 28% in Q1 2026, selling an estimated $663K and leaving 24,113 shares worth $1.56M. The position accounts for 0.04% of the portfolio, ranked #387.

Vestcor Inc first reported a position in HALO in Q4 2022 and has held it in 12 quarters since. The position peaked at $3.14M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Vestcor Inc held 24,113 shares of Halozyme worth $1.56M as of Q1 2026.
Vestcor Inc sold 9,399 Halozyme shares in Q1 2026, an estimated $663K.
Halozyme made up 0.04% of Vestcor Inc's portfolio in Q1 2026, its #387 holding.
Vestcor Inc first reported a position in Halozyme in Q4 2022 and has held it in 12 quarters since.
Vestcor Inc's Halozyme position peaked at $3.14M in Q3 2025.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.